Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines

• Published in: European journal of pharmacology Vol. 346; no. 1; pp. 87 - 95
• Main Authors: VAN LIEFDE, I, VANDERHEYDEN, P. M. L, FRAEYMAN, N, DE BACKER, J.-P, VAUQUELIN, G
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier 03.04.1998
• Subjects: Animals; Arginine - analogs & derivatives; Arginine - pharmacology; Biological and medical sciences; Cell Line; CHO Cells; Colforsin - pharmacology; Cricetinae; Cyclic AMP - metabolism; Humans; Hydrogen-Ion Concentration; Kinetics; Medical sciences; Neuropeptide Y - metabolism; Neuropharmacology; Neurotransmitters. Neurotransmission. Receptors; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems; Pharmacology. Drug treatments; Radioligand Assay; Receptors, Neuropeptide Y - antagonists & inhibitors; Receptors, Neuropeptide Y - physiology; Tumor Cells, Cultured; Human; Neuropeptide Y; Cell culture; Cyclic AMP; Acidification; Peptidergic receptor; Neuroblastoma; Extracellular; In vitro
• ISSN: 0014-2999; 1879-0712
• DOI: 10.1016/S0014-2999(97)01619-1

The ability of the human neuropeptide YY1 receptor subtype to increase the extracellular acidification rate in different cell lines was investigated by using the Cytosensor Microphysiometer. In CHO-Y1 cells (Chinese Hamster Ovary cells expressing the cloned human neuropeptide YY1 receptor), neuropeptide Y increased the acidification rate by up to 15% of the basal level with a -Log(EC50) of 7.42. As expected for neuropeptide YY1 receptors, this response was potently inhibited by the neuropeptide YY1-selective non-peptide antagonist BIBP3226 ((R)-N2-(diphenylacetyl)-N-[(4-hydroxy-phenyl)methyl]-D-arginine amide). Its enantiomer BIBP3435 ((S)-N2-(diphenylacetyl)-N-[(4-hydroxy-phenyl)methyl]-D-arginin amide) was less potent. The antagonists themselves did not affect the extracellular acidification rate at concentrations up to 10 microM. In SK-N-MC cells (a neuroblastoma cell line of human origin that expresses the neuropeptide YY1 receptor) no change of the acidification rate could be observed in the presence of neuropeptide Y at concentrations up to 1 microM. For control, the neuropeptide YY1 receptors were also investigated by assessing whole cell radioligand binding and, at the functional level, by assessing their ability to decrease the forskolin-induced accumulation of cAMP. The specific (i.e., neuropeptide Y-displaceable) binding of [3H]neuropeptide Y was to a homogeneous class of high-affinity sites in both SK-N-MC and CHO-Y1 cells. The equilibrium dissociation constants for [3H]neuropeptide Y, the total number of binding sites and the kinetic constants for association and for dissociation were similar. Neuropeptide Y produced a dose-dependent inhibition of forskolin-induced cAMP accumulation in SK-N-MC cells (-log(EC50) = 9.40) but it did not affect cAMP accumulation in CHO-Y1 cells. Non-transfected CHO-K1 cells were used as negative control throughout the study. No binding or response could be observed in these cells. Our data suggest that the signalling mechanisms of neuropeptide YY1 receptors are closely related to the cell type in which they are expressed.